Collegium Pharmaceutical Inc (COLL)
32.44
-1.23
(-3.65%)
USD |
NASDAQ |
May 17, 16:00
32.44
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Price: 32.44 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 33.67 | 33.74 | 32.38 | 32.47 | 384883.0 |
| May 16, 2024 | 33.82 | 34.11 | 33.32 | 33.67 | 378713.0 |
| May 15, 2024 | 33.41 | 34.81 | 33.30 | 33.98 | 1.168M |
| May 14, 2024 | 32.75 | 33.33 | 31.79 | 33.29 | 732658.0 |
| May 13, 2024 | 33.18 | 33.37 | 31.37 | 32.15 | 884500.0 |
| May 10, 2024 | 33.01 | 34.00 | 30.42 | 31.50 | 2.254M |
| May 09, 2024 | 38.31 | 38.60 | 37.60 | 37.86 | 363978.0 |
| May 08, 2024 | 37.25 | 38.28 | 37.22 | 38.06 | 316992.0 |
| May 07, 2024 | 37.04 | 37.64 | 37.00 | 37.30 | 199326.0 |
| May 06, 2024 | 37.51 | 37.92 | 36.88 | 37.02 | 304924.0 |
| May 03, 2024 | 37.80 | 38.32 | 37.29 | 37.51 | 300393.0 |
| May 02, 2024 | 38.16 | 38.16 | 37.18 | 37.51 | 312815.0 |
| May 01, 2024 | 37.12 | 38.47 | 37.03 | 37.78 | 369821.0 |
| Apr 30, 2024 | 36.93 | 38.18 | 36.75 | 36.93 | 370516.0 |
| Apr 29, 2024 | 36.51 | 37.17 | 36.51 | 36.71 | 219512.0 |
| Apr 26, 2024 | 35.95 | 36.57 | 35.79 | 36.42 | 252821.0 |
| Apr 25, 2024 | 35.37 | 36.01 | 35.05 | 35.84 | 338007.0 |
| Apr 24, 2024 | 35.83 | 36.02 | 35.33 | 35.48 | 302816.0 |
| Apr 23, 2024 | 35.00 | 36.51 | 34.92 | 35.94 | 618659.0 |
| Apr 22, 2024 | 34.93 | 35.31 | 34.55 | 34.74 | 414728.0 |
| Apr 19, 2024 | 34.65 | 35.34 | 34.24 | 34.84 | 325386.0 |
| Apr 18, 2024 | 35.47 | 35.47 | 34.69 | 34.77 | 203939.0 |
| Apr 17, 2024 | 35.47 | 35.75 | 34.76 | 35.45 | 256530.0 |
| Apr 16, 2024 | 35.03 | 35.81 | 34.74 | 35.40 | 323773.0 |
| Apr 15, 2024 | 35.67 | 35.98 | 35.12 | 35.14 | 366303.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
10.16
Minimum
Jul 22 2019
40.91
Maximum
Mar 27 2024
21.19
Average
20.67
Median
Aug 26 2021
Price Benchmarks
| Catalyst Pharmaceuticals Inc | 16.49 |
| Supernus Pharmaceuticals Inc | 29.09 |
| AnaptysBio Inc | 25.06 |
| Recursion Pharmaceuticals Inc | 9.42 |
| Nuvalent Inc | 70.95 |
Price Related Metrics
| PE Ratio | 13.47 |
| PS Ratio | 2.693 |
| Price to Book Value | 4.781 |
| Price to Free Cash Flow | 4.954 |
| Earnings Yield | 7.42% |
| Market Cap | 1.062B |
| Operating PE Ratio | 7.959 |
| Normalized PE Ratio | 13.47 |